Effect of adenomyosis on prognosis of patients with endometrial cancer
Rev. Assoc. Med. Bras. (1992, Impr.)
;
69(7): e20221720, 2023. tab, graf
Article
in English
|
LILACS-Express
| LILACS
| ID: biblio-1449092
ABSTRACT
SUMMARY OBJECTIVE:
Our goal was to contrast the prognoses of patients with endometrial cancer who had adenomyosis against those that did not.METHODS:
All patients who had received surgical staging for hysterectomy-based endometrial cancer had their medical data retrospectively examined. The analysis covered 397 patients, who were split into two groups depending on the presence of adenomyosis. Comparisons were made between patients covering type of surgery, histopathology, endometrial cancer stage, lymphovascular space invasion, presence of biochemical or histochemical markers, adjuvant therapy, presence of adenomyosis in the myometrial wall, and outcomes in terms of overall survival and disease-free survival.RESULTS:
There is no statistically significant difference in the 5-year disease-free survival or overall survival rates between endometrial cancer patients with and without adenomyosis. This is based on comparisons of tumor stage, tumor diameter, histological type and grade of tumor, myometrial invasion, lymphovascular space invasion, and biochemical markers that affect the course of the disease. The median follow-up times were 61 months for the adenomyosis-positive group and 56 months for the group without adenomyosis.CONCLUSION:
Coexisting adenomyosis in endometrial cancer has no bearing on survival rates and is not a prognostic factor.
Full text:
Available
Index:
LILACS (Americas)
Type of study:
Prognostic study
Language:
English
Journal:
Rev. Assoc. Med. Bras. (1992, Impr.)
Journal subject:
EducaÆo em Sa£de
/
GestÆo do Conhecimento para a Pesquisa em Sa£de
/
Medicine
Year:
2023
Type:
Article
Affiliation country:
Turkey
Institution/Affiliation country:
Istanbul Medipol University/TR
/
University of Health Sciences Turkey/TR
Similar
MEDLINE
...
LILACS
LIS